ArticleJournal of orthopaedic surgery and research2025
Integrating bioinformatics, molecular dynamics simulation and experimental verification to screen diagnostic biomarkers for polyamine metabolism-related osteoarthritis and predict potential drugs.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOsteoarthritis (OA) represents a prevalent chronic joint degeneration disorder regulated by multiple factors. Polyamine metabolism (PM) contributes substantially to OA development. However, the underlying mechanism remains unclear. The current study aimed to identify PM-related OA biomarkers and to discover potential therapeutic small-molecule compounds (SMCs). The goal was to lay the groundwork for future diagnostic and therapeutic approaches for OA.
methodsThe current study screened differentially expressed PM-related genes (DEPMGs) by integrating data from the Gene Expression Omnibus and GeneCards databases. Next, functional annotations were performed for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Weighted gene co-expression network analysis (WGCNA) was used to pinpoint crucial modular genes. Then, four machine learning algorithms were employed to determine the hub genes. Their diagnostic efficacy was evaluated via nomogram models and receiver operating characteristic curves. We screened SMCs with potential for treating OA through molecular docking and molecular dynamics simulations. Finally, to validate the expression of the aforementioned biomarkers, qRT-PCR and Western blot experiments were performed in a hydrogen peroxide (H
resultsFirst, thirty DEPMGs were screened. GO and KEGG enrichment analyses revealed their involvement in biological processes, including the cellular response to lipopolysaccharide, chondrogenesis, and the IL-17 signaling pathway. Using WGCNA and machine learning, four hub genes were identified. Molecular docking and molecular dynamics simulations revealed that triptolide exhibited a strong binding affinity with the target protein and that the binding system demonstrated excellent stability. In vitro experiments revealed that the four hub genes were significantly upregulated in OA (p < 0.05), consistent with the bioinformatics predictions.
conclusionsThis study initially identified four genes closely associated with polyamine metabolism-related genes: PLOD1, TSPO, SPP1, and COL6A1. These genes demonstrated potential value in the early diagnosis and precise intervention of OA. Triptolide was also found to have therapeutic potential for treating OA. These findings lay the groundwork for developing OA biomarkers and innovative therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.